Objective: This review discusses the relationship between cannabis use and psychotic, bipolar, depressive, and anxiety disorders, as well as suicide. It summarizes epidemiological evidence from cross-sectional and long-term prospective studies and considers possible etiological mechanisms. Methods: Systematic reviews and methodologically robust studies in the field (from inception to February 2019) were identified using a comprehensive…
Journal of Dual Diagnosis Template
Write in a clean editor, then format for Journal of Dual Diagnosis in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Dual Diagnosis format
Journal of Dual Diagnosis is a peer-reviewed journal published by Taylor & Francis, covering Substance Abuse Treatment and Outcomes, Schizophrenia research and treatment, Smoking Behavior and Cessation.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Dual Diagnosis 12 (3): 45–58.
Formats any DOI in Journal of Dual Diagnosis style. No sign-up. |
| Publishes research in | Substance Abuse Treatment and Outcomes Schizophrenia research and treatment Smoking Behavior and Cessation Mental Health Treatment and Access Posttraumatic Stress Disorder Research |
| ISSN | 1550-4263 |
| Citation impact (2-yr) | 1.18 |
| h-index | 45 |
| i10-index | 296 |
| Total citations | 9,484 |
| Top institutions publishing here | Dartmouth College |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Dual Diagnosis per year
Citation impact of Journal of Dual Diagnosis by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Dual Diagnosis
Schizophrenia is a common mental illness with a high prevalence of smoking. More than 80% of schizophrenics smoke compared to 25% of the general population. Both schizophrenia and tobacco use have strong genetic components, which may overlap. It has been suggested that smoking in schizophrenia may be a form of self-medication in an attempt to…
OBJECTIVE: Mobile technology has the potential to radically improve addiction treatment and continuing care by offering emotional and instrumental support anywhere and just in time. This is particularly important in addiction because timing is critical to preventing relapse. Although most experts consider alcoholism to be a chronic disease, providers do not typically offer ongoing support…
The objective of this article was to propose a novel approach, referred to as the study of trans-disease processes (TDPs), to the neuroscientific study of disease processes in general and to co-morbid diseases in particular. The features of this approach are outlined; one potential TDP-delay discounting, which may help account for the co-morbidity of cigarette…
Stimulant use disorder is an important public health problem, with an estimated 2.1 million current users in the United States alone. No pharmacological treatments are approved by the U.S. Food and Drug Administration for stimulant use disorder and behavioral treatments have variable efficacy and limited availability. Most individuals with stimulant use disorder have other comorbidities,…